Loading
The Thermo Fisher Scientific subsidiary that the FDA names as maker of the Oncomine Dx tests and other companion diagnostics.
Life Technologies Corporation is the maker the FDA companion diagnostic list names for the Oncomine Dx Express Test, the Oncomine Dx Target Test and the SPOT-LIGHT HER2 CISH Kit. The FDA PMA record for the Oncomine Dx Express Test (P240040, approved 2 July 2025) gives the applicant's address as Frederick, Maryland. Thermo Fisher Scientific lists Life Technologies Corporation, a Delaware company, among its subsidiaries in the exhibit to its annual report for 2025.
Thermo Fisher's newer sequencing test for lung cancer, companion to sunvozertinib for EGFR exon 20 insertions and to sevabertinib for HER2 mutations.
Shares Oncomine Dx Express Test, Thermo Fisher Scientific, Companion diagnostics, Non-small-cell lung cancer.
Shares Oncomine Dx Express Test, Non-small-cell lung cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/